Comparison of clinical, biochemical and morphological parameters in patients with chronic hepatitis B

Vanja Nickovic ,
Vanja Nickovic
Andrijana Odalovic ,
Andrijana Odalovic
Jelena Aritonovic ,
Jelena Aritonovic
Boban Stolic
Boban Stolic

Published: 01.12.2016.

Volume 46, Issue 3 (2017)

pp. 13-17;

https://doi.org/10.5937/pramed1704013n

Abstract

Introduction: Hepatitis B virus is primarily hepatotropic, causing chronic hepatitis B in 5-10% of patients. Chronic hepatitis B (CHB) infection is a dynamic process, which may have five phases: immunotolerant, immunoactive, latency phase, reactive and HBsAg negative phase. Aim: Analyze clinical and biochemical parameters in relation to morphological condition of the liver. Material and Methods: The study enrolled 35 patients diagnosed with CHB, 24 males and 11 females, aged between 12 and 62 years, in the period 2015-2016. The diagnosis was based on serological, biochemical results, and liver biopsy. In patients in an ELISA assay demonstrated the presence of HBsAg in serum. Results: The study shows that middle-aged male patients are more prone to chronic hepatitis B infection. Most patients have one or two symptoms.Fatigue and right subcostal pain are most commonly present in the groups with fibrosis in second- and third-degree,and hepatomegaly in the group with fibrosis in first-degree. Splenomegaly is present only in groups with fibrosis in third and fourth degree. Elevated average aminotransaminase levels reflected the degree of fibrosis. Significant statistical difference in aminitransaminase levels was confirmed between the group of patients with third- and forth-degree and patients without fibrosis. Conclusion: The increase in ALT levels reflect the degree of fibrosis and cirrhosis of the occurrence. ALT levels may be a predictor of the process of the fibrogenesis, as well as to indicate the degree of fibrosis in HHB infection. Due to frequent discrepancies between clinical manifestations and results of laboratory tests, liver biopsy has been considered “gold standard” for establishing the diagnosis, staging chronic hepatitis B, making therapeutic decisions, monitoring the course of the disease, and assessing prognosis.

Keywords

References

1.
Delic D. Hronični virusni hepatitisi. Beograd: Zavod za udžbenike i nastavna sredstva. 2012;
2.
Catherine M, Croagh J, Lubel. Natural history of chronic hepatitis B: Phases in a complex relationship. World J Gastroenterol. 2014;(30):10395–404.
3.
Wong S, Hann H. Hepatitis B-related hepatocellular carcinoma, Critical review. Hepatology. 2013;(1):7.
4.
Delić D. Hronični virusni hepatitis B i C. Moje zdravlje. 2015;
5.
World Health Organiyation P. Hepatitis B vaccine. Wklu Epidemiol Rec. 2015;225–63.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by